Inflammatory Response in Amebic Liver Abscess

  • L. E. Muñoz

Abstract

In the inflammatory response humoral and cellular effector systems participate during acute as well as chronic inflammation (1,3). The main effector systems that are involved in the acute inflammatory process are: a) the complement system in particular C3a, C3e, C5a, C5b, C567 and factor B (2); b) coagulation and fibrinolytic systems, and c) acute phase reactants (2). Some cells are attracted to the site of inflammation by humoral processes. These cells are polymorphonuclear (PMN); basophils; eosinophils; monocytes; lymphocytes and platelets mainly. Fluid mediators derived from these cells participate in inflammatory regulation (2,3). Plasma mediators of acute inflammation inhibit or amplify these mechanisms.

Keywords

Cellulose Albumin Gall Eter Sarcoidosis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    D.H. Wright, Immunological aspects of diagnostic histopathoIogy,in: “Clinical Aspects of Immunology,” PGH. Gell, RRA Coombs and PJ Lachmann, eds., Blackwell Scientific Publications, London, 783p (1975).Google Scholar
  2. 2.
    P.M. Henson, Antibody and immune-complex-mediated allergic and inflammatory reactions, in: “Clinical Aspects of Immunology,” PJ. Lachmann and DK Peters, eds., Blackwell Scientific Publications, London, 687p (1982).Google Scholar
  3. 3.
    RN. Pinckard, The “new” chemical mediators of inflammation, in: “Current Topics in Inflammation and Infection,” Williams and Wilkins, London, 38p (1982).Google Scholar
  4. 4.
    H. Brandt and R. Perez-Tamayo, “Amibiasis,” 1a. ed., La Prensa Médica Mexicana, México (1970).Google Scholar
  5. 5.
    D. Trissl, Immunology of Entamoeba histolytica in human and animal host, Rev. Infect. Dis. 4: 1154 (1982).PubMedCrossRefGoogle Scholar
  6. 6.
    S. Meri, G. Richaud and E. Linder, Complement activation by antigenic fractions of Entamoeba histolytica, Parasite Immunol. 7: 153 (1985).PubMedCrossRefGoogle Scholar
  7. 7.
    S. L. Reeds, J. G. Curd, I. Gigli, F. D. Gillin and A. I. Braude, Activation of complement by pathogenic and nonpathogenic Entamoeba histolytica, J Immunol. 136: 2265 (1986).Google Scholar
  8. 8.
    L. Ortiz-Ortiz, R. Capin N. R. Capin, B. SepuIveda and G. Zamacona, Activation of the alternative pathway of complement by Entamoeba histolytica, Clin. Exp. Immunol. 34: 10 (1978).PubMedGoogle Scholar
  9. 9.
    G. Huldt, P. Davies, A. C. Allison, H. U. Schorlommer, Interactions between Entamoeba histolytica and complement, Nature 277–214 (1979). ID.Google Scholar
  10. 10.
    L. E. Muñoz and O. G. Salazar, Complement activation in patients with amebic liver abscess, J. Hepatol. 5: 30 (1987).PubMedCrossRefGoogle Scholar
  11. 11.
    H. J. Müller-Eberhard and R. D. Schreiber, Molecularbiology and chemistry of the alternative pathway of complement, Adv.. Immunol. 29: 1 (1980).PubMedCrossRefGoogle Scholar
  12. 12.
    NK. Pangburn and HJ. Müller-Eberhard, The alternative pathway of complement, Springer Semin. Immunopathol. 7: 163 (1984)Google Scholar
  13. 13.
    G. C. Tsokos, G. Inghirami, C. D. Tsoukas, J. E. BaIow and J. D. Lambris, Regulation of immunoglobulin secretion by factor H of serum human complement, Immunol. 55: 419 (1985).Google Scholar
  14. 14.
    B. Sepulveda and A. Martinez-PaIomo, Immunology of amebiasis by Entamoeba histolytica, in “Immunology of Parasitic Infections” S. Cohen and K. Warren, eds., Blackwell Scientific Publications, Great Britain, 170p (1982).Google Scholar
  15. 15.
    A.A. Abioye, E. A. Lewis and H. Mc Farlane, Clinical evaluation of serum immunoglobulins in amoebiasis, Immunol. 23: 937 (1972).Google Scholar
  16. 16.
    V. V. Ravi, S. Mithal, A. N. Malaviya and B. N. Tandom, Immunologic studies in amebic liver abscess, Indian J.Med. Res. 63: 1732 (1975).PubMedGoogle Scholar
  17. 17.
    A. Dasgupta, Immunoglobulins in health and disease. III.Immunoglobulins in the sera of patients with amoebiasis, Clin. Exp. Immuno I. 86 163 (1974).Google Scholar
  18. 18.
    J. 0. S. Osisanya and D. C. Warhurst, Spec ific antiamebic immunoglobulins and the cellulose acetate precipitin test in Entamoeba histolytica infection, Trans. Roy. Soc. Trop. Med. Hyg. 74: 605 (1980).PubMedCrossRefGoogle Scholar
  19. 19.
    N.K. Ganguly, R. C. Mahajan, D. V. Datta, S. Sharma, P. N. Chuttani, and A. K. Gupta, Immunoglobulin and complement levels in cases of invasive amoebiasis, Indian J. Med. Res.. 67: 221 (1978).Google Scholar
  20. 20.
    O. Muñoz. R. Hernandez-Velarde, E. Cruz-Mejia and M. C. Martinez, Es posible distinguir entre infeccion hepatica antigua y reciente mediante el analisis inmunoenzi matico. Arch. Invest. Med. (Mex.) 17 (SuppI.): 327 (1986)Google Scholar
  21. 21.
    J. Ibarra, “Aspectos de la respuesta inmune humoral en pacientes con absceso hepatico amibiano,” Tesis de licenciatura para Q.F.B., U.A.N.L. Facultad de Ciencias Quimicas (inedita), Monterrey, N.L. Mex. Septiembre. 1987.Google Scholar
  22. 22.
    R.A. Salata, A. Martinez-Palomo, H. W. Murray, L. Canales, N. Revino, E. Segovia, C. F. Murphy and J. I. Ravdin, Patients treated for amebic liver abscess develop cell- mediated immune responses effective in vitro against Entamoeba histolytica, J. Immunol. 136 (7): 2633 (1986).PubMedGoogle Scholar
  23. 23.
    A. Perches, R. Kretschmer, E. Lee, B. Sepulveda, Determinacion de inmunoglobulinas en suero de pacientes conamibiasis invasora, Arch. Invest. Med. (Mex.) 1 (Suppl.): s97 (1970).Google Scholar
  24. 24.
    H. Bazin, The secretory antibody system, in “Immunological Aspects of the Liver and Gastrointestinal Tract,” A. Ferguson, R. N. M. Mac Sween eds., M. T. P. Press Ltd., Great Britain, 33p (1976).Google Scholar
  25. 25.
    JR. David, Host-Parasite interface: Immunology, in: “Tropical and Geographical Medicine,” K. S. Warren and A. F. Mahmoud, eds., Mac Graw-Hill, New York, 125p (1985)Google Scholar
  26. 26.
    K Ishizaka and T. Ishizaka, Biological functions of gamm a IgE antibodies and mechanisms of reaginic hypersensitivity, Clin. Exp.. Immunol. 6: 25 (1970).PubMedGoogle Scholar
  27. 27.
    I.M. Krupp and J. Powell, Comparative study of the antibody response in amebiasis, Am. J. Trop. Med,. Hyg. 20:Google Scholar
  28. 28.
    M. Krupp, Definition of the antigenic pattern of Entamoeba histolytica, and immunoeIectrophoretic analysis of the variation of patient response to amebic disease, Am. J. Trop. Med. Hyg. 26: 387 (1977).PubMedGoogle Scholar
  29. 29.
    R. Campos-Rodriguez, O. Diaz-Guerra, C. Barranco-Tovar, A. Isibasi-Araujo, J. Kumate-Rodriguez, Papel de la IgA en la eliminacion de antigenos amibianos, Arch. Invest. Med. (Mex.) 17: 353 (1986).Google Scholar
  30. 30.
    R. Capin, A. Gonzalez-Mendoza, L. Ortiz-Ortiz, Disminuci on de la actividad del sistema fagocitico mononuclear en hamsters infectados con Entamoeba histolytica, Arch. Invest. Med. (Mex.) ll(Suppl 1 ): 235 (1980Google Scholar
  31. 31.
    R. Kretschmer, M.C. Salinas-Carmona, M. Lopez-Osuna and M. A. Avila, Efecto de Entamoeba histolytica sobre la quimiotaxis de monocitos humanos, Arch.Invest. Med. (Mex.) 11 (SuppI 1): 147 (1980).Google Scholar
  32. 32.
    N. Gosh and F. C. Sen, Phagocytic function in amebiasis, Indian J. Med. Res. 71: 207 (1980).Google Scholar
  33. 33.
    J. Gill, N. K. Ganguly, R.C. Mahajan, S.R. Bhusnurmath and J.B. Dilawari, Monocyte functions in human amebiasis, Indian J. Med. Res. 76: 674 (1782).Google Scholar
  34. 34.
    R. L. Guerrant, J. Brush, J. I. Ravdin, J. A. Sullivan and G. L. Mandell, Interactions between Entamoeba histolytica and human polymorphonuclear neutrophilis, J. Infect. Dis. 143: 83 (1981).PubMedCrossRefGoogle Scholar
  35. 35.
    L. E. Muffoz-Espinosa and O. G. Sa Iazar-FI ores, Systemic inflammation in patients with amebic liver abscess: Chemotaxis of polymorphonuclear cells, Arch. Invest. Med. (Mex.) 17 (Suppl.): 313 (1986).Google Scholar
  36. 36.
    P. C. Wilkinson, “Chemotaxis and Inflammation, ”Churchill Livingstone, Great Britain, 168p (1974).Google Scholar
  37. 37.
    EL. Becker and PA Ward, Chemotaxis, In: “Clinical Immunology,” CW. Parker, ed., Saunders Co., Philadelphia 272p (1983).Google Scholar
  38. 38.
    D. E. Van Epps and J. R. Jr Williams, Suppression of leukocyte Chemotaxis by human IgA components, J. Exp. Med. 144: 1227 (1976).PubMedCrossRefGoogle Scholar
  39. 39.
    DE. Van Epps, K. Reed and JRC Jr. Williams, Suppression of human PMN bactericidal activity by human IgA paraproteins. Cell. Immunol. 36: 363 (1978).PubMedCrossRefGoogle Scholar
  40. 40.
    J. A. Berenberg and P. A. Ward, Chemotactic factor inactivator in normal human serum, J. Clin. Invest. 52: 120 (1973).CrossRefGoogle Scholar
  41. 41.
    R. A. Rabins, R. K. Zetterman, T. J. Kendall, G. L. Gossman, H. P. Monsour and R. I. Rennard, Elevation of chemotactic factor inactivator in alcoholic liver disease, Hepatol. 7 (5): 872 (1987).CrossRefGoogle Scholar
  42. 42.
    G. Till and P. A. Ward, Two distinct chemotactic factor inactivators in human serum, J,. Immunol 114 (2): 843 (1975).Google Scholar
  43. 43.
    R.A. Clark, Disorders of granulocyte Chemotaxis, in:“Leukocyte Chemotaxis: Methods Physiology and Clinical Implications”, J.I. Gallin and PG. Quiet, eds., Raven Press, New York, 329p (1978).Google Scholar
  44. 44.
    E. G. Maderazo, T. F. Antoni and P. A. Ward, Serum associated inhibitor of leukotaxis in humans with cancer, Clin. Immunol. Immunopathol. 9: 166 (1978).PubMedCrossRefGoogle Scholar
  45. 45.
    J. P. Brozna and P. A. Ward, Antileukotactic properties of tumor cells. J. Clin. Invest. 56: 616 (1975).PubMedCrossRefGoogle Scholar
  46. 46.
    S. Said-Fernandez, J. Vargas-Villarreal and J. Castro-Garza, Mecanismo multifactorial de la actividad citolitica de Entamoeba histolytica, Arch. Invest. Med (Mex.) 17 (Suppl): 173 (1986Google Scholar
  47. 47.
    JM. Weiler, Complement and the immune response, i n:“Complement in Health and Disease,” K. Whaley, ed., M. T. P. Press Ltd., Norwell, MA. U. S. A. 289P (1987).Google Scholar
  48. 48.
    S. Pillai, A. Mohimen, A. solid phase sandwich radioimmunoassay for E. histolytica antigen and the detection of circulating antigen in amebiasis, Gastroenterols 83: 1210 (1982).Google Scholar
  49. 49.
    T. K. Maitra, N. K. Jalan, A. Mohimen, Detection of E. histolytica immune complexes in human tissues by a solid phase sandwich assay, Memorias del X Seminario sobre Amibiasis, 45p, Octubre, Mexico. City, (1986).Google Scholar
  50. 50.
    B. Sepulveda, Amibiasis: Host-pathogen biology, Rev. Infect. Dis. 4: 836 (1982).CrossRefGoogle Scholar
  51. 51.
    G. M. Faubert, E. Meerovitch, J. Mc. Kaughlin, the presence of liver auto-antibodies induced by Entamoeba histolytica in the sera from naturally infected humans and immunized rabbits, Am. J. Trop. Med. Hyg. 27: 872 (1978).Google Scholar
  52. 52.
    P. Mavier, A. M. Preaux, J. Rosenbaum, B. Guigui and D. Dhumeaux, Toxicity of PMN cells against hepatocytes. Evidence for an oxygen-dependent and independt mechanism, J. HepatoI. SuppI. 2: S282 (1985).Google Scholar
  53. 53.
    M. J. P. Arthur, Reactive oxygen intermediates and liver Injury, J. Hepatol. 6: 125 (1988).PubMedCrossRefGoogle Scholar
  54. 54.
    V. Tsutsumi, R. Mena-Lopez, F. Anaya-VeIazquez and A. Martinez-Palomo, Cellular bases of experimental amebic liver abscess formation, Am. J. Pathol. 117: 81 (1984).PubMedGoogle Scholar
  55. 55.
    J. C. Fantone, P. A. Ward, Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions, Am. J. Pathol. 107: 397 (1982).Google Scholar
  56. 56.
    P.J. Lachmann and DK. Peters, Complement, in “Clinical Aspects of Immunology,” PJ. Lachmann and DK. Peters, eds., 4th. Ed., Blackwell Scientific Publications, London, 18p (1982).Google Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • L. E. Muñoz
    • 1
  1. 1.Unidad de Hígado,Facultad de Medicina y HospitalUniversitario “Dr. José E. González”, Universidad Autónoma de Nuevo LeónMonterrey, N.L.México

Personalised recommendations